TrialHaematologica2024

Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: influence of demographic, pharmacological, and genetic factors in the German CML-PAED cohort.

Sophie Stiehler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.